Dominique Figarella‐Branger

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

85h-index37.4kcitations880works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(340), Meningioma and schwannoma management(104), Neuroblastoma Research and Treatments(94), Brain Metastases and Treatment(75), Pituitary Gland Disorders and Treatments(61)

Publications871 total

Integrated 3D Light-Sheet and 2D Multiplex Imaging for Deep Histological Profiling of a Somatic Mouse Glioblastoma Model
2025Open Access
BIOS-01. CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE
Neuro-Oncology·2025Open Access
Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter Study
Neurosurgery·2025
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas
Journal of Neuro-Oncology·2025
P12.51.B INTEGRATIVE MULTIOMIC ANALYSIS IDENTIFIES EIF4A1 AND CDK9 AS KEY THERAPEUTIC TARGETS IN OLIGODENDROGLIOMAS
Neuro-Oncology·2025Open Access
P12.59.B CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE
Neuro-Oncology·2025Open Access
P14.14.A 3D VOLUME GROWTH RATE OPENS NEW PERSPECTIVES FOR THE CLASSIFICATION OF AGGRESSIVE PITUITARY ADENOMAS
Neuro-Oncology·2025Open Access
<scp>cIMPACT</scp> ‐ <scp>NOW</scp> update 11: Proposal on adaptation of diagnostic criteria for <scp>IDH</scp> ‐ and <scp>H3</scp> ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors
Brain Pathology·2025· 8 citedOpen Access
The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells
Cancer Cell International·2025· 4 citedOpen Access
Reply to “The time has come for an integrated and multiscale grading system for oligodendrogliomas <i>IDH</i>-mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters”
Neuro-Oncology·2025· 1 cited
Comparative Clinical and Imaging‐Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL Amplification
Neuropathology and Applied Neurobiology·2025· 2 citedOpen Access
The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cells
2025Open Access
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas <i>IDH</i>‐mutant and 1p/19q codeleted: A French POLA network study
Cancer·2025· 1 citedOpen Access
Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study
ESMO Gastrointestinal Oncology·2025· 2 citedOpen Access
Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment
Journal of Experimental & Clinical Cancer Research·2024· 9 citedOpen Access
Phenotypic and epigenetic heterogeneity in <i>FGFR2</i> ‐fused glial and glioneuronal tumours
Neuropathology and Applied Neurobiology·2024· 1 citedOpen Access
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort
Neuro-Oncology·2024· 8 citedOpen Access
Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study
EBioMedicine·2024· 8 citedOpen Access
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
Journal of Clinical Oncology·2024· 20 cited
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis
American Journal of Neuroradiology·2024· 7 citedOpen Access
page 1 of 44Next →

Frequent Co-authors

Felice Giangaspero(9), Olivier Chinot(9), Pieter Wesseling(8), David W. Ellison(7), Guido Reifenberger(6), David Capper(6), Torsten Pietsch(6), Anne Jouvet(6), Jacques Grill(6), David N. Louis(5), Arie Perry(5), Andreas von Deimling(5), Caterina Giannini(5), Werner Paulus(5), Jacqueline Trouillas(5), Thierry Brue(5), Henry Dufour(5), Karima Mokhtari(5), Daniel J. Brat(4), Stefan M. Pfister(4)